Delivery Order SPE2DB22D2211-SPE2DB25FRNEM

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $60K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,382.76 and is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract is a Firm Fixed Price arrangement, with an ultimate completion date of August 15, 2024. This award is associated with an Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S to the Defense Logistics Agency (DLA), a defense agency. The contract has an award value of $13,343.13 and a completion date of December 16, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $11,907.38 and an ultimate completion date of November 21, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $25,373.64 and an ultimate completion date of April 11, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract was awarded on a firm fixed-price basis with no set-aside designation, indicating open competition....
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $22,751.89 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 1, 2024. The contract has a firm fixed price and an ultimate completion date of August 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $33,316.21. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of November 4, 2024. This award is not associated with a set-aside designation,...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price contract type. The award, valued at $51,182.66, has a ceiling value of $51,182.66 and an ultimate completion date of December 20, 2024. The prime contractor for this award is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a Child contract under a larger...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a Firm Fixed Price basis. The ceiling value of the contract is $5,879.40, with a performance period through February 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $5,077.97, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 18, 2024, with a completion date of December 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery...
This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,503.14 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 22, 2024, with a completion date of April 23, 2024. The award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRNEM
    Delivery Order

This federal contract award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $60,124.37 and a completion date of January 6, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not indicate the use of any set-aside designations.

Generated 4/4/25, 9:43 AM